enGene Holdings Inc. Common Stock
Symbol: ENGN (NASDAQ)
8.41
▲ (6.92%) 0.544
Company Description:
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Key Stats
- Today's Open: $7.94
- Today's High: $8.619
- Today's Low: $7.745
- Today's Volume: 104.44K
- Yesterday Close: $7.865
- Yesterday High: $8.42
- Yesterday Low: $7.7
- Yesterday Volume: 80.30K
- Last Min Volume: 0
- Last Min High: $8.409
- Last Min Low: $8.404
- Last Min VWAP: $0
Company Profile
- Name: enGene Holdings Inc. Common Stock
- Website: https://www.engene.com
- Listed Date: 2023-11-01
- Location: SAINT-LAURENT, A8
- Market Status: Active
- CIK Number: 0001980845
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $423.10M
- Round Lot: 100
- Outstanding Shares: 51.19M
- Asset Type: CS
RECENT FILINGS FOR ENGN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-02 | 8-K | View |
| 2025-10-02 | 8-K/A | View |
| 2025-10-01 | 4 | View |
| 2025-10-01 | 3 | View |
| 2025-09-30 | 8-K | View |
| 2025-09-11 | S-8 | View |
| 2025-09-11 | 10-Q | View |
| 2025-09-11 | 8-K | View |
| 2025-09-03 | 8-K | View |
| 2025-07-14 | 4 | View |
| 2025-07-14 | 3 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-08 | 3 | View |
| 2025-07-08 | 3 | View |
| 2025-07-08 | 3 | View |
| 2025-07-08 | 3 | View |
| 2025-07-08 | 8-K | View |
Latest News on ENGN